Published in J Biol Chem on August 19, 2009
Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes (2013) 1.41
Clostridium difficile toxins: mediators of inflammation. J Innate Immun (2012) 1.21
The enterotoxicity of Clostridium difficile toxins. Toxins (Basel) (2010) 1.07
Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex. Proc Natl Acad Sci U S A (2013) 1.03
Clostridium difficile infection. Nat Rev Dis Prim (2016) 0.99
Cholera- and anthrax-like toxins are among several new ADP-ribosyltransferases. PLoS Comput Biol (2010) 0.96
Clostridium and bacillus binary enterotoxins: bad for the bowels, and eukaryotic being. Toxins (Basel) (2014) 0.91
Clostridial binary toxins: iota and C2 family portraits. Front Cell Infect Microbiol (2011) 0.86
(1)H, (13)C, and (15)N resonance assignments of an enzymatically active domain from the catalytic component (CDTa, residues 216-420) of a binary toxin from Clostridium difficile. Biomol NMR Assign (2016) 0.82
Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling. Mol Aspects Med (2013) 0.81
Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT. Sci Rep (2015) 0.80
The 1.8 Å cholix toxin crystal structure in complex with NAD+ and evidence for a new kinetic model. J Biol Chem (2012) 0.80
Obstructing toxin pathways by targeted pore blockage. Chem Rev (2012) 0.80
Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure. J Biol Chem (2015) 0.78
Expression, purification, crystallization and preliminary crystallographic analysis of a putative Clostridium difficile surface protein Cwp19. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains. PLoS One (2017) 0.75
Functional significance of active site residues in the enzymatic component of the Clostridium difficile binary toxin. Biochem Biophys Rep (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature (1992) 36.50
Satisfying hydrogen bonding potential in proteins. J Mol Biol (1994) 14.79
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature (1995) 6.08
Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev (2005) 5.69
Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Botulinum C2 toxin ADP-ribosylates actin. Nature (1986) 3.16
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun (1988) 3.11
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev (2004) 2.60
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
Clostridium perfringens iota toxin ADP-ribosylates skeletal muscle actin in Arg-177. FEBS Lett (1987) 1.85
Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex. Nat Struct Biol (1999) 1.78
A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins. FEBS J (2006) 1.49
Botulinum C2 toxin ADP-ribosylates actin and disorganizes the microfilament network in intact cells. Eur J Cell Biol (1987) 1.37
Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu Rev Microbiol (2008) 1.35
Review of Clostridium difficile-associated diseases. Am J Infect Control (1986) 1.34
Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens iota-toxin. Proc Natl Acad Sci U S A (2008) 1.31
Crystal structure and site-directed mutagenesis of enzymatic components from Clostridium perfringens iota-toxin. J Mol Biol (2003) 1.25
Structure and action of the binary C2 toxin from Clostridium botulinum. J Mol Biol (2006) 1.20
Analysis of the catalytic site of the actin ADP-ribosylating Clostridium perfringens iota toxin. FEBS Lett (1996) 1.17
A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins. J Pharmacol Exp Ther (1982) 1.15
Characterization of the enzymatic component of Clostridium perfringens iota-toxin. J Bacteriol (2000) 1.13
Lethal and vascular permeability activities of botulinum C2 toxin induced by separate injections of the two toxin components. Infect Immun (1983) 1.11
ADP-ribosylation of actin isoforms by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin. Eur J Biochem (1990) 1.03
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet (2006) 3.88
The CCN family of proteins: structure-function relationships. Trends Biochem Sci (2008) 2.82
Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature (2003) 2.78
Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry (2004) 1.86
Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci (2002) 1.85
A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins. FEBS J (2006) 1.49
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc Natl Acad Sci U S A (2006) 1.41
Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet (2007) 1.40
Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. J Biol Chem (2009) 1.25
Structural basis of ordered binding of donor and acceptor substrates to the retaining glycosyltransferase, alpha-1,3-galactosyltransferase. J Biol Chem (2002) 1.24
Crystal structure of an active form of human MMP-1. J Mol Biol (2006) 1.20
Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. J Biol Chem (2002) 1.17
Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem (2002) 1.12
Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J Mol Biol (2006) 1.12
Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry (2007) 1.12
Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1. J Biol Chem (2006) 1.12
Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. Protein Sci (2007) 1.08
Roles of individual enzyme-substrate interactions by alpha-1,3-galactosyltransferase in catalysis and specificity. Biochemistry (2003) 1.08
Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme. Biochem J (2003) 1.06
Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. Structure (2003) 1.06
Conformational changes induced by binding UDP-2F-galactose to alpha-1,3 galactosyltransferase- implications for catalysis. J Mol Biol (2007) 1.05
Super toxins from a super bug: structure and function of Clostridium difficile toxins. Biochem J (2011) 1.05
Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry (2003) 1.04
The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407. J Biol Chem (2010) 1.03
Superantigens: structure-function relationships. Int J Med Microbiol (2004) 1.01
Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nat Commun (2012) 1.00
Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 cell polarization. J Allergy Clin Immunol (2006) 1.00
Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor. J Biol Chem (2004) 0.99
High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors. Protein Sci (2003) 0.99
Roles of active site tryptophans in substrate binding and catalysis by alpha-1,3 galactosyltransferase. Glycobiology (2004) 0.97
Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase. Proc Natl Acad Sci U S A (2005) 0.96
The crystal structure of C3stau2 from Staphylococcus aureus and its complex with NAD. J Biol Chem (2003) 0.95
High-resolution crystal structures of Drosophila melanogaster angiotensin-converting enzyme in complex with novel inhibitors and antihypertensive drugs. J Mol Biol (2010) 0.95
Chimeric microtubule disruptors. Chem Commun (Camb) (2010) 0.92
The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody. Structure (2003) 0.92
Crystal structures of Erythrina cristagalli lectin with bound N-linked oligosaccharide and lactose. Glycobiology (2004) 0.91
Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides. Sci Rep (2012) 0.91
Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile. Protein Expr Purif (2010) 0.90
The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380. Biochemistry (2007) 0.90
Crystal structure of protoporphyrinogen oxidase from Myxococcus xanthus and its complex with the inhibitor acifluorfen. J Biol Chem (2006) 0.90
Structure of mouse IP-10, a chemokine. Acta Crystallogr D Biol Crystallogr (2008) 0.90
Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines. FEBS J (2011) 0.90
Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons. Cell Microbiol (2011) 0.90
Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain. Mov Disord (2004) 0.89
Role of placenta growth factor in cardiovascular health. Trends Cardiovasc Med (2002) 0.89
Crystal structure of a phosphonotripeptide K-26 in complex with angiotensin converting enzyme homologue (AnCE) from Drosophila melanogaster. Biochem Biophys Res Commun (2010) 0.89
Atomic resolution (0.98 A) structure of eosinophil-derived neurotoxin. Biochemistry (2002) 0.89
Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase. J Biol Chem (2008) 0.88
The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals. FEBS Lett (2012) 0.87
Structural basis of UDP-galactose binding by alpha-1,3-galactosyltransferase (alpha3GT): role of negative charge on aspartic acid 316 in structure and activity. Biochemistry (2008) 0.87
Structure of testis ACE glycosylation mutants and evidence for conserved domain movement. Biochemistry (2006) 0.87
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin A. Biochem Biophys Res Commun (2009) 0.86
Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A. Protein Expr Purif (2002) 0.86
Screening a limited structure-based library identifies UDP-GalNAc-specific mutants of alpha-1,3-galactosyltransferase. Glycobiology (2008) 0.86
The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. Biochemistry (2002) 0.86
Engineered botulinum neurotoxins as new therapeutics. Annu Rev Pharmacol Toxicol (2013) 0.85
Eosinophil-granule major basic protein, a C-type lectin, binds heparin. Biochemistry (2005) 0.85
Mutational analysis of the complex of human RNase inhibitor and human eosinophil-derived neurotoxin (RNase 2). Biochemistry (2003) 0.85
Family 6 glycosyltransferases in vertebrates and bacteria: inactivation and horizontal gene transfer may enhance mutualism between vertebrates and bacteria. J Biol Chem (2010) 0.85
Preparation of specifically activatable endopeptidase derivatives of Clostridium botulinum toxins type A, B, and C and their applications. Protein Expr Purif (2005) 0.84
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template. J Med Chem (2010) 0.83
Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity. J Biol Chem (2010) 0.83
Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE). J Biol Chem (2013) 0.83
Crystallographic studies on the role of the C-terminal segment of human angiogenin in defining enzymatic potency. Biochemistry (2002) 0.83
Localization of an N-domain region of angiotensin-converting enzyme involved in the regulation of ectodomain shedding using monoclonal antibodies. J Proteome Res (2005) 0.83
Binding of non-natural 3'-nucleotides to ribonuclease A. FEBS J (2005) 0.82
Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41. Biochemistry (2004) 0.82
Ribonuclease A homologues of the zebrafish: polymorphism, crystal structures of two representatives and their evolutionary implications. J Mol Biol (2008) 0.82
Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors. Biochemistry (2010) 0.82
Angiotensin-I converting enzyme (ACE): structure, biological roles, and molecular basis for chloride ion dependence. Biol Chem (2014) 0.81
Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes. J Mol Biol (2007) 0.81
Influence of naturally-occurring 5'-pyrophosphate-linked substituents on the binding of adenylic inhibitors to ribonuclease a: an X-ray crystallographic study. Biopolymers (2009) 0.81
Structure of murine angiogenin: features of the substrate- and cell-binding regions and prospects for inhibitor-binding studies. Acta Crystallogr D Biol Crystallogr (2005) 0.81
Molecular recognition of chymotrypsin by the serine protease inhibitor ecotin from Yersinia pestis. J Biol Chem (2011) 0.81
Biological and structural features of murine angiogenin-4, an angiogenic protein. Biochemistry (2007) 0.81
Identification of a secondary zinc-binding site in staphylococcal enterotoxin C2. Implications for superantigen recognition. J Biol Chem (2003) 0.80
Structural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin B. J Biol Chem (2001) 0.80
Guest-host crosstalk in an angiogenin-RNase A chimeric protein. Biochemistry (2002) 0.80
First structural glimpse of CCN3 and CCN5 multifunctional signaling regulators elucidated by small angle x-ray scattering. J Biol Chem (2011) 0.80
Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor. J Mol Biol (2005) 0.80
Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B. J Struct Biol (2010) 0.80
Engineering toxins for 21st century therapies. FEBS J (2011) 0.79
Time course and temperature dependence of the membrane translocation of tetanus and botulinum neurotoxins C and D in neurons. Biochem Biophys Res Commun (2012) 0.79
Structure of a metal-independent bacterial glycosyltransferase that catalyzes the synthesis of histo-blood group A antigen. Sci Rep (2012) 0.79
Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agent. Biochem J (2005) 0.79
C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure. Acta Crystallogr D Biol Crystallogr (2004) 0.79
Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide. Biochem J (2011) 0.79
Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril. FEBS J (2011) 0.78
Structures of engineered Clostridium botulinum neurotoxin derivatives. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.78
Structures of native human thymidine phosphorylase and in complex with 5-iodouracil. Biochem Biophys Res Commun (2009) 0.78
Superantigens. Structure, function, and diversity. Methods Mol Biol (2003) 0.78